The ANGIOMAX Mechanism of Action

Hybrid was selected by The Medicines Company and their agency Lifebrands USA to create a 10-minute animation centered on the role of thrombin in coagulation and intracoronary thrombosis and inflammation.

During 10 minutes of dramatic, realistic imagery, viewers journey past close-up depictions of plaque rupture and clot formation.

While the main purpose of the animation was for large-screen projection at key society meetings, Hybrid produced the animation in a way that allowed the client to re-purpose key segments into “mini-chapters.” These smaller segments appear on an interactive CD version of the animation that was produced for use by sales represenatives and their customers.

The sequence featured here is from the final chapter which depicts the mechanism of action of ANGIOMAX.